Bioer FQD-A1600 Integrated Automated Nucleic Acid Purification and Real-Time Fluorescent PCR Analysis System

Overview

The Bioer FQD-A1600 Integrated Automated Nucleic Acid Purification and Real-Time Fluorescent PCR Analysis System is an end-to-end molecular diagnostics platform engineered for walkaway automation in clinical, public health, and research laboratories. It combines magnetic-bead-based nucleic acid isolation with high-precision real-time quantitative PCR (qPCR) amplification and detection in a single, closed instrument architecture. Unlike modular or semi-automated workflows, the FQD-A1600 performs sample tube uncapping, primary sample partitioning, lysis, binding, washing, elution, PCR master mix dispensing, reaction setup, thermal cycling, and fluorescence signal acquisition—without manual intervention. Its core thermocycling engine employs Peltier-based rapid heating/cooling modules calibrated to meet ISO 13485-aligned temperature control specifications, ensuring compliance with CLIA, CAP, and ISO 15189 pre-analytical and analytical validation requirements.

Key Features

• Fully integrated sample-to-answer workflow: automates nucleic acid purification (magnetic bead chemistry), qPCR assay setup, and real-time amplification/detection in one instrument.
• Modular throughput design: processes 1–16 samples per run with on-demand scheduling; supports continuous loading via sequential sample rack insertion.
• Contamination-controlled environment: sealed processing chambers with active negative pressure ventilation, HEPA-filtered exhaust, and UV decontamination cycles between runs.
• High-fidelity thermal performance: achieves ≤±0.1 °C temperature accuracy across all 16 wells and ≤±0.3 °C inter-well uniformity—critical for multiplex assay reproducibility and low-copy target quantification.
• Rapid thermal ramping: ≥10 °C/s maximum heating rate enables shortened cycle times without compromising amplification efficiency or probe hybridization kinetics.
• Intuitive human-machine interface: 10.1-inch capacitive touchscreen with role-based access control (operator, supervisor, administrator) and audit-trail-enabled session logging.

Sample Compatibility & Compliance

The FQD-A1600 accepts primary clinical specimens including EDTA-anticoagulated whole blood, flocked nylon swabs in viral transport media, midstream urine, and homogenized tissue lysates. It supports both DNA and RNA extraction using standardized reagent kits validated under ISO 20387 (biobanking) and ISO/IEC 17025 (testing laboratory competence). The system’s closed-tube processing meets CDC-recommended biosafety Level 2 (BSL-2) containment guidelines and aligns with WHO IVD regulatory expectations for molecular diagnostic platforms. All firmware and software modules comply with FDA 21 CFR Part 11 requirements for electronic records and signatures, including full audit trail generation, user authentication, and data integrity safeguards.

Software & Data Management

The embedded Bioer qPCR Analysis Suite v3.2 provides real-time fluorescence curve visualization, automatic Ct value calculation, multi-parameter threshold setting, and MIQE-compliant reporting templates. Raw fluorescence data (.rdml format) and processed results (.xlsx, .pdf) are exportable via encrypted USB or network transfer. The system supports LIMS integration through ASTM E1384-compliant HL7 messaging and offers optional cloud-based data backup with AES-256 encryption. All software updates undergo rigorous version-controlled validation per IEC 62304 Class B medical device software standards.

Applications

• Clinical infectious disease testing: SARS-CoV-2, influenza A/B, RSV, HPV genotyping, and antimicrobial resistance gene profiling.
• Public health surveillance: high-throughput screening of wastewater samples or pooled respiratory specimens.
• Transplant monitoring: quantification of donor-derived cell-free DNA (dd-cfDNA) in recipient plasma.
• Veterinary diagnostics: detection of zoonotic pathogens such as Brucella spp., Leptospira, and avian influenza subtypes.
• Academic research: gene expression analysis, SNP genotyping, and miRNA profiling where batch consistency and operator-independent reproducibility are essential.

FAQ

Does the FQD-A1600 support third-party reagents or only Bioer-branded kits?

Yes—it accepts open-platform magnetic bead kits compliant with ISO 15197 and CLSI EP22-A guidelines, provided they match the instrument’s liquid handling volume range (20–200 µL) and magnetic separation timing profiles.
What is the maximum daily capacity under continuous operation?

With staggered sample loading and automated cleaning cycles, the system achieves up to 768 samples per 24-hour period—assuming average run time of 120 minutes per 16-sample batch.
Is remote monitoring or troubleshooting supported?

Yes—via secure TLS 1.2-enabled web portal with real-time status dashboard, predictive maintenance alerts, and technician remote access (with dual-factor authentication).
How is calibration verified and maintained?

The system includes built-in NIST-traceable thermal calibration verification using reference dyes (ROX, Cy5), performed automatically before each run and logged with timestamped metadata.
Can the instrument be integrated into existing laboratory middleware systems?

Yes—through configurable DICOM-SR, ASTM E1384, or RESTful API interfaces supporting bidirectional order/result exchange with major LIS/HIS platforms.